Cargando…
Brexpiprazole augmentation in a clozapine-resistant young schizophrenic patient: a successful case report.
INTRODUCTION: Although clozapine is considered the most effective drug for Treatment Resistant Schizophrenia (TRS), only 40% of patients treated will meet clinical response. Literature reviews and meta-analytic data offer no definite conclusions about the most effective clozapine augmentation strate...
Autores principales: | Martiadis, V., Raffone, F., Russo, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478854/ http://dx.doi.org/10.1192/j.eurpsy.2023.2317 |
Ejemplares similares
-
Clozapine-Treatment-Resistant Schizophrenia Successfully Managed with Brexpiprazole Combination Therapy: Two Case Reports
por: Orsolini, L., et al.
Publicado: (2022) -
Metacognition, emotional dysregulation, psychosocial functioning and subjective well-being after 6 months of CBT treatment in pharmacologically stabilized schizophrenic patients
por: Raffone, F., et al.
Publicado: (2023) -
Intranasal Esketamine + CBT: a 6 months follow-up of a resistant depression complicated case
por: Martiadis, V., et al.
Publicado: (2022) -
Intranasal esketamine + Intensive CBT: a 12 months follow-up of two complicated cases of Treatment Resistant Depression at high suicidal risk
por: Martiadis, V., et al.
Publicado: (2023) -
The Problem Schizophrenic : Clozapine or ECT?
por: Andrade, C.
Publicado: (1996)